Honex Korea Co.,Ltd., Groundbreaking ceremony for exclusive factory for pre-filled injection - Completion in April next year, appointment of President Kim Tae Sung - Honex Korea Co., Ltd. (Representative Yoo Sung-jae) announced on Nov 23 that it has installed a 'pre-filled formulation injecting agent (pre-filled formulation filled in a syringe) factory' with a building area of 2,500 m2 on the 13,892 m2 site of the Megapolies Industrial complex (Choong-ju city) Private factory groundbreaking ceremony was held. Established in 1991, Honex Korea Co., Ltd. has been developing with the growth of tertiary medical institutions for 25 years. In particular, we have been manufacturing, supplying and supplying third party GMP facilities for cancer patients and patients with severe illness.   Honex Korea Co., Ltd. has long been planning the need for a factory dedicated to high-tech injector facilities so that patients who come to the hospital can be reliably treated from all infectious diseases caused by injections. Honex Korea Co., Ltd. has been working on GMP certification at its own factory, activating the research center, and designing future for the purpose of developing patient-centered treatment for each disease by linking with the leading medical industry research center hospitals both at home and abroad. In addition, Honex Korea is planning and conducting a number of products exported to the US as a future-oriented strategy. Kim Tae-sung, who is from Seoul College of Chemistry, has been recruited as a specialist to participate in the construction of the factory. He is planning to complete the construction by the end of April 2017.